| 000 | 03598nam a22003975i 4500 | ||
|---|---|---|---|
| 999 |
_c80454 _d80454 _x1 |
||
| 001 | 80454 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230207040306.0 | ||
| 006 | a||||fo|||| 00| 0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 131004s2014 gw | s |||| 0|eng d | ||
| 020 | _a9783540723141 | ||
| 024 | 7 |
_a10.1007/978-3-540-72314-1 _2doi |
|
| 040 |
_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC |
||
| 050 | 4 |
_aRM845 _b2014 EB |
|
| 245 | 0 | 0 |
_aALERT - Adverse Late Effects of Cancer Treatment : _bVolume 1: General Concepts and Specific Precepts _cedited by Philip Rubin, Louis S. Constine, Lawrence B. Marks. |
| 264 | 1 |
_aBerlin, Heidelberg _bSpringer _c2014 |
|
| 300 |
_a1 recurso en línea (XXIV, 311 p.) _b93 ilustraciones, 43 ilustraciones en color |
||
| 336 |
_aTexto _btxt _2rdacontent |
||
| 337 |
_aelectrónico _bc _2rdamedia |
||
| 338 |
_arecurso electrónico _bcr _2rdacarrier |
||
| 490 | 1 |
_aMedical Radiology _x0942-5373 |
|
| 505 | 0 | _aBioContinuum of Effects of Multimodal Therapy -- BioMolecular Mechanisms and Pathways of Normal Tissue Damage -- BioPathology of Radiation and Chemotherapy -- BioImaging of the Longitudinal Normal Tissue Injury -- BioScoring Systems for Acute and Late Effects -- BioPediatric Complexities of Growth and Development -- Bioepidemiology -- BioGenetic and Host Implications -- Radiotherapy-Induced Biocarcinogenesis and Leukemogenesis -- BioManagement and BioPrevention.-BioSurveillance and Longitudinal Lifelong Guidelines -- Specific Precept: Medical Legal Issues: Malpractice Issues -- Insurance, Economics: Cost of Care -- Nursing -- Psychologic Issues -- Social Worker Issues: Quality of Life and Activities of Daily Living. | |
| 520 | _aThe literature on the late effects of cancer treatment is widely scattered in different journals since all major organ systems are affected and management is based on a variety of medical and surgical treatments. The aim of ALERT â€{u0064}verse Late Effects of Cancer Treatment is to offer a coherent multidisciplinary approach to the care of cancer survivors. The central paradigm is that cytotoxic multimodal therapy results in a perpetual cascade of events that affects each major organ system differently and is expressed continually over time. Essentially, radiation and chemotherapy are intense biologic modifiers that allow for cancer cure and cancer survivorship but accelerate senescence of normal tissues and increase the incidence of age-related diseases and second malignant tumors. Volume 1 of this two-volume work focuses on the general concepts and principles relevant to late effects and on the dynamic interplay of molecular, cytologic and histopathologic events that lead to altered physiologic and metabolic functions and their clinical manifestations. Chapters are also included on legal issues, economic aspects, nursing, psychological issues and quality of life. | ||
| 988 | _aEBOOK, EBSPRINGER | ||
| 650 | 7 |
_aRadioterapia _0LocalW _2embne _9139979 |
|
| 650 | 7 |
_aDiagnóstico por imagen _2embne _9139972 |
|
| 650 | 7 |
_aMedicina nuclear _2embne _9138396 |
|
| 700 | 1 |
_aRubin, Philip _eeditor literario _934848 _0comprobar BNE20030418351 |
|
| 700 | 1 |
_aConstine, Louis S. _eeditor literario _0Local _988644 |
|
| 700 | 1 |
_aMarks, Lawrence B. _eeditor literario _0Local _988645 |
|
| 710 | 2 |
_aSpringerLink (Online service) _0Local _9106996 |
|
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-3-540-72314-1 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 942 |
_2lcc _cLE |
||
| 998 |
_b10/2020 _dz _eIG _feng _ggw _h0 |
||